# EDGAR Filing Document

**Accession Number:** 0001796129
**File Stem:** 0001387131-23-001893
**Filing Date:** 2023-2
**Character Count:** 9940
**Document Hash:** 9cc4e8dda343b8a78b23249ff0fccecd
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001387131-23-001893.hdr.sgml**: 20230213

**ACCESSION NUMBER**: 0001387131-23-001893

**CONFORMED SUBMISSION TYPE**: SC 13G/A

**PUBLIC DOCUMENT COUNT**: 1

**FILED AS OF DATE**: 20230213

**DATE AS OF CHANGE**: 20230213

**GROUP MEMBERS**: AFFINITY HEALTHCARE FUND, LP

**SUBJECT COMPANY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Vincerx Pharma, Inc.
- **CENTRAL INDEX KEY:** 0001796129
- **STANDARD INDUSTRIAL CLASSIFICATION:** PHARMACEUTICAL PREPARATIONS [2834]
- **IRS NUMBER:** 833197402
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** SC 13G/A
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 005-91457
- **FILM NUMBER:** 23618529

**BUSINESS ADDRESS:**
- **STREET 1:** 260 SHERIDAN AVENUE
- **STREET 2:** SUITE 400
- **CITY:** PALO ALTO
- **STATE:** CA
- **ZIP:** 94306
- **BUSINESS PHONE:** 650-800-6676

**MAIL ADDRESS:**
- **STREET 1:** 260 SHERIDAN AVENUE
- **STREET 2:** SUITE 400
- **CITY:** PALO ALTO
- **STATE:** CA
- **ZIP:** 94306

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Vincera Pharma, Inc.
- **DATE OF NAME CHANGE:** 20201223

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** LifeSci Acquisition Corp.
- **DATE OF NAME CHANGE:** 20191206
**FILED BY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Affinity Asset Advisors, LLC
- **CENTRAL INDEX KEY:** 0001773195
- **IRS NUMBER:** 821567490
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** SC 13G/A

**BUSINESS ADDRESS:**
- **STREET 1:** 767 THIRD AVENUE
- **STREET 2:** 15TH FLOOR
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10017
- **BUSINESS PHONE:** 917-826-4533

**MAIL ADDRESS:**
- **STREET 1:** 767 THIRD AVENUE
- **STREET 2:** 15TH FLOOR
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10017

**UNITED STATES<br> SECURITIES AND EXCHANGE COMMISSION<br> Washington, D.C. 20549**

**SCHEDULE 13G**

**Under the Securities Exchange Act of 1934<br> (Amendment No. 2)\***

Vincerx Pharma, Inc.

(Name of Issuer)

Common Stock, par value $0.0001 per share

(Title of Class of Securities)

92731L106

(CUSIP Number)

Michael Hirschberg, Esq.

Reitler Kailas & Rosenblatt LLP

885 Third Avenue, 20th Floor

New York, NY 10022

(Name, Address and Telephone Number of Person<br> Authorized to Receive Notices and Communications)

December 31, 2022

(Date of Event which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:<br> ◻ Rule 13d-1(b)<br> ⌧ Rule 13d-1(c)<br> ◻ Rule 13d-1(d)

<sup>\*</sup> The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

CUSIP No. 92731L106 13G Page 2 of 7 Pages

1. NAMES OF REPORTING PERSONS<br>
 I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)<br>
 <br> Affinity Healthcare Fund, LP (EIN 82-1629802)

2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP<br>
(see instructions)<br>
(a) ☐<br>
(b) ☐

3. SEC USE ONLY<br>

4. CITIZENSHIP OR PLACE OF ORGANIZATION<br>
 Delaware

---

| | | |
|:---|:---|:---|
| NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH | 5. | SOLE VOTING POWER |
| NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH | 6. | SHARED VOTING POWER<br>1,492,771 shares of Common Stock<br>|
| NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH | 7. | SOLE DISPOSITIVE POWER<br>|
| NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH | 8. | SHARED DISPOSITIVE POWER<br>1,492,771 shares of Common Stock<br>|

---

9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON <br>
1,492,771 shares of Common Stock

10. CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES<br>
(see instructions) ☐

11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) <br>
7.04%

12. TYPE OF REPORTING PERSON (see instructions) PN

CUSIP No. 92731L106 13G Page 3 of 7 Pages

1. NAMES OF REPORTING PERSONS<br>
 I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)<br>
 <br> Affinity Asset Advisors, LLC (EIN 82-1567490)

2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP<br>
(see instructions)<br>
(a) ☐<br>
(b) ☐

3. SEC USE ONLY<br>

4. CITIZENSHIP OR PLACE OF ORGANIZATION<br>
 Delaware

---

| | | |
|:---|:---|:---|
| NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH | 5. | SOLE VOTING POWER<br>|
| NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH | 6. | SHARED VOTING POWER<br>1,492,771 shares of Common Stock<br>|
| NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH | 7. | SOLE DISPOSITIVE POWER<br>|
| NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH | 8. | SHARED DISPOSITIVE POWER<br>1,492,771 shares of Common Stock <br>|

---

9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON <br>
1,492,771 shares of Common Stock

10. CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES<br>
(see instructions) ☐

11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) <br>
7.04%

12. TYPE OF REPORTING PERSON (see instructions) IA

CUSIP No. 92731L106 13G Page 4 of 7 Pages

**Item 1.**

(a) **Name of Issuer:<br>** <br> Vincerx Pharma, Inc.

(b) **Address of Issuer's Principal Executive Offices:<br>** <br> 260 Sheridan Avenue, Suite 400 Palo Alto, CA 94306

**Item 2.**

(a) **Name of Persons Filing:<br>** <br> Affinity Healthcare Fund, LP<br>
 Affinity Asset Advisors, LLC

(b) **Address of Principal Business Office or, if None, Residence:<br>** <br> 767 Third Avenue, 15<sup>th</sup> Floor New York, NY 10017

(c) **Citizenship:<br>** <br> Affinity Healthcare Fund, LP and Affinity Asset Advisors, LLC - Delaware

(d) **Title of Class of Securities:<br>** <br> Common Stock, par value $0.0001 per share

(e) **CUSIP Number:** 92731L106

CUSIP No. 92731L106 13G Page 5 of 7 Pages

**Item 3. If this statement is filed pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:**

(a) ◻ Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o).

(b) ◻ Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c).

(c) ◻ Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c).

(d) ◻ Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8).

(e) ◻ An investment adviser in accordance with §240.13d-1(b)(1)(ii)(E);

(f) ◻ An employee benefit plan or endowment fund in accordance with §240.13d-1(b)(1)(ii)(F);

(g) ◻ A parent holding company or control person in accordance with §240.13d-1(b)(1)(ii)(G);

(h) ◻ A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);

(i) ◻ A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);

(j) ◻ A non-U.S. institution in accordance with §240.13d-1(b)(1)(ii)(J);

(k) ◻ Group, in accordance with §240.13d-1(b)(1)(ii)(K).

CUSIP No. 92731L106 13G Page 6 of 7 Pages

**Item 4. Ownership.**

Affinity Asset Advisors, LLC (the "Advisor") is the investment manager of Affinity Healthcare Fund, LP (the "Fund") and exercises investment discretion with regard to the securities reported herein. As of December 31, 2022, the Fund beneficially owned an aggregate of 1,492,771 shares of Common Stock of the Issuer, or 7.04% of the outstanding shares of Common Stock of the Issuer, and the Advisor may be deemed to be the beneficial owner of such 1,492,771 shares of Common Stock of the Issuer owned by the Fund by virtue of its position as investment manager of the Fund. The Fund and the Advisor have the shared power to vote or to direct the vote and to dispose or direct the disposition of 1,492,771 shares of Common Stock of the Issuer.

The percentage set forth in the preceding paragraph and in Row 11 of the cover page for each reporting person is based on 21,189,769 shares of Common Stock of the Issuer outstanding as of October 31, 2022, as reported in the Issuer's Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2022 filed with the Securities and Exchange Commission on November 10, 2022.

**Item 5. Ownership of Five Percent or Less of a Class.**

Not Applicable

**Item 6. Ownership of More than Five Percent on Behalf of Another Person.**

Not Applicable

**Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company.**

Not Applicable

**Item 8. Identification and Classification of Members of the Group.**

Not Applicable

**Item 9. Notice of Dissolution of Group.**

Not Applicable

**Item 10. Certification.**

By signing below, we certify that, to the best of our knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.

CUSIP No. 92731L106 13G Page 7 of 7 Pages

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

---

| |
|:---|
| February 13, 2023<br> Date |
| <br> **Affinity Healthcare Fund, LP** |
| By: /s/ Michael Cho<br> Signature<br>**AFFINITY ASSET ADVISORS, LLC**<br>By: /s/ Michael Cho<br> Signature<br>|

---